One in 6 parents approve teen cosmetic procedures; US poll
HQ Team February 17, 2025: A recent U.S. national poll indicates that 1 in 6 parents support their teens undergoing non-surgical cosmetic procedures.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team February 17, 2025: A recent U.S. national poll indicates that 1 in 6 parents support their teens undergoing non-surgical cosmetic procedures.
HQ Team February 15, 2025: A study by the American Cancer Society (ACS) found mortality risks for smoking menthol cigarettes were higher than non-menthol.
Infant Mortality Increase in States with Abortion Bans: An In-Depth Analysis HQ Team February 15, 2025:Two recent studies published in the Journal of the.
HQ Team February 14, 2025: Multidrug-resistant tuberculosis (MDR-TB) among children worldwide is a “silent epidemic” that needs immediate intervention. New data reveals that.
Forty-nine bodies, likely of migrants, were found in two mass graves in Libya, according to the UN agency, the International Office of Migration.
Bain Capital, a US-based private investment company, will buy the pharmaceutical arm of the Mitsubishi Chemical Group Corp. for $3.3 billion, according to.
Indians are struggling to maintain a balance between digital workplace and life, with just three out of 100 individuals, according to a survey,.
Globus Medical, a US-based medical device company, will buy Nevro Corp. for $250 million in an all-cash deal.
United Therapeutics Corporation, a public benefit corporation, got approval from US regulators to start a clinical trial for organ transplantation from genetically modified.
HQ Team February 6, 2025: The U.S. Food and Drug Administration (FDA) issued a critical Class I recall—the most severe category—for Medtronic’s Becker.